Search research articles
Contact Us
Filters
Showing results (341-350 of 365) with videos related to
Page
of 37
Sort By:
Journal of Gastroenterology
|
April 24, 2015
NY-ESO-1 autoantibody as a tumor-specific biomarker for esophageal cancer: screening in 1969 patients with various cancers
Yoko Oshima, Hideaki Shimada, Satoshi Yajima, et al.
Oncology Reports
|
December 23, 2022
Identification of antibody against wingless‑type MMTV integration site family member 7B as a biliary cancer tumor marker
Mizuna Takahashi, Takahiro Tsuchikawa, Takaki Hiwasa, et al.
Communications Medicine
|
January 28, 2026
Selective blockade of latent TGF-β1 activation suppresses tissue fibrosis with good safety
Masakazu Kanamori, Izumi Sato, Christine Xing'er Koo, et al.
Journal of Clinical Medicine Research
|
January 6, 2025
The Impact on Patient Prognosis of Changes to the Method of Notifying Staff About Accepting Patients With Out-of-Hospital Cardiac Arrest
Youichi Inoue, Keisuke Okamura, Hideaki Shimada, et al.
Oncotarget
|
February 12, 2015
Haploinsufficiency of the c-myc transcriptional repressor FIR, as a dominant negative-alternative splicing model, promoted p53-dependent T-cell acute lymphoblastic leukemia progression by activating Notch1
Kazuyuki Matsushita, Kouichi Kitamura, Bahityar Rahmutulla, et al.
Mabs
|
March 16, 2022
Comprehensive engineering of a therapeutic neutralizing antibody targeting SARS-CoV-2 spike protein to neutralize escape variants
Taichi Kuramochi, Siok Wan Gan, Adrian W S Ho, et al.
Cancer Immunology Research
|
January 24, 2018
Combination Gemcitabine and WT1 Peptide Vaccination Improves Progression-Free Survival in Advanced Pancreatic Ductal Adenocarcinoma: A Phase II Randomized Study
Sumiyuki Nishida, Takeshi Ishikawa, Shinichi Egawa, et al.
Journal of Translational Medicine
|
June 3, 2018
Selective pharmacological inhibition of DDR1 prevents experimentally-induced glomerulonephritis in prevention and therapeutic regime
Solange Moll, Yukari Yasui, Ahmed Abed, et al.
Annals of Surgical Oncology
|
November 19, 2020
New Assay System Elecsys Anti-p53 to Detect Serum Anti-p53 Antibodies in Esophageal Cancer Patients and Colorectal Cancer Patients: Multi-institutional Study
Satoshi Yajima, Takashi Suzuki, Yoko Oshima, et al.
International Journal of Clinical Oncology
|
March 17, 2024
Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2
Yoshinori Kikuchi, Hideaki Shimada, Fumiyuki Yamasaki, et al.
Page
of 37
Search research articles
Search
Showing results (341-350 of 365) with videos related to
Sort By:
Page
of 37
Journal of Gastroenterology
|
April 24, 2015
NY-ESO-1 autoantibody as a tumor-specific biomarker for esophageal cancer: screening in 1969 patients with various cancers
Yoko Oshima, Hideaki Shimada, Satoshi Yajima, et al.
Oncology Reports
|
December 23, 2022
Identification of antibody against wingless‑type MMTV integration site family member 7B as a biliary cancer tumor marker
Mizuna Takahashi, Takahiro Tsuchikawa, Takaki Hiwasa, et al.
Communications Medicine
|
January 28, 2026
Selective blockade of latent TGF-β1 activation suppresses tissue fibrosis with good safety
Masakazu Kanamori, Izumi Sato, Christine Xing'er Koo, et al.
Journal of Clinical Medicine Research
|
January 6, 2025
The Impact on Patient Prognosis of Changes to the Method of Notifying Staff About Accepting Patients With Out-of-Hospital Cardiac Arrest
Youichi Inoue, Keisuke Okamura, Hideaki Shimada, et al.
Oncotarget
|
February 12, 2015
Haploinsufficiency of the c-myc transcriptional repressor FIR, as a dominant negative-alternative splicing model, promoted p53-dependent T-cell acute lymphoblastic leukemia progression by activating Notch1
Kazuyuki Matsushita, Kouichi Kitamura, Bahityar Rahmutulla, et al.
Mabs
|
March 16, 2022
Comprehensive engineering of a therapeutic neutralizing antibody targeting SARS-CoV-2 spike protein to neutralize escape variants
Taichi Kuramochi, Siok Wan Gan, Adrian W S Ho, et al.
Cancer Immunology Research
|
January 24, 2018
Combination Gemcitabine and WT1 Peptide Vaccination Improves Progression-Free Survival in Advanced Pancreatic Ductal Adenocarcinoma: A Phase II Randomized Study
Sumiyuki Nishida, Takeshi Ishikawa, Shinichi Egawa, et al.
Journal of Translational Medicine
|
June 3, 2018
Selective pharmacological inhibition of DDR1 prevents experimentally-induced glomerulonephritis in prevention and therapeutic regime
Solange Moll, Yukari Yasui, Ahmed Abed, et al.
Annals of Surgical Oncology
|
November 19, 2020
New Assay System Elecsys Anti-p53 to Detect Serum Anti-p53 Antibodies in Esophageal Cancer Patients and Colorectal Cancer Patients: Multi-institutional Study
Satoshi Yajima, Takashi Suzuki, Yoko Oshima, et al.
International Journal of Clinical Oncology
|
March 17, 2024
Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2
Yoshinori Kikuchi, Hideaki Shimada, Fumiyuki Yamasaki, et al.
Page
of 37